NICE backs Ocrevus for PPMS in England - but with caveats  pharmaphorum

NICE has recommended regular NHS funding for Roche's Ocrevus, although there are still restrictions on its use.

View full coverage on Google News
NICE has recommended regular NHS funding for Roche’s Ocrevus, although there are still restrictions on its use.NICE has recommended regular NHS funding for Roche’s Ocrevus, although there are still restrictions on its use.

NHS backing of a new treatment for the disease means Zoe Bowman may get help just as her sister has.NHS backing of a new treatment for the disease means Zoe Bowman may get help just as her sister has.

We both now have hope - MS sisters - BBC News

Good news! NICE approves Ocrevus (ocrelizumab) for primary progressive MS

Good news! NICE approves Ocrevus (ocrelizumab) for primary progressive MS | MS Trust

“On @itvnews at 1:30pm,a huge break-through for suffers of MS. We talk to one of them and the charity @mssociety, who are celebrating.”

Alastair Stewart on Twitter: "On @itvnews at 1:30pm,a huge break-through for suffers of MS. We talk to one of them and the charity @mssociety, who are celebrating."

“WJZ responded out of fear, managing to both overreact and underreact at the same time. It was a sad moment for journalism, on top of Ms. Bubala’s phrasing, and a missed opportunity to further a crucial conversation. @triciabishop @baltsunopinion https://t.co/aml0jYmwd9”

Dan Rodricks on Twitter: "WJZ responded out of fear, managing to both overreact and underreact at the same time. It was a sad moment for journalism, on top of Ms. Bubala’s phrasing, and a missed opportunity to further a crucial conversation. @triciabishop @baltsunopinion https://t.co/aml0jYmwd9"

“My first online contest with ms_4_ms has officially come to a close! 💥🔸💥🔸💥🔸💥🔸💥 We had over 50 entries and we reached over 1,000 people as we continue spreading awareness of Multiple Sclerosis in support of all the… https://t.co/vbRbe5PxEa”

Dario Pizzano on Twitter: "My first online contest with ms_4_ms has officially come to a close! 💥🔸💥🔸💥🔸💥🔸💥 We had over 50 entries and we reached over 1,000 people as we continue spreading awareness of Multiple Sclerosis in support of all the… https://t.co/vbRbe5PxEa"

“I had a great discussion w/ the wonderful folks from the @MSAtlantic Society, a cause that is dear to me, having seen the impact of #MultipleSclerosis on relatives and friends. For anyone seeking support with #MS, #MSNavigators is a great support resource: https://t.co/ESp5lBFtal”

Geoff Regan on Twitter: "I had a great discussion w/ the wonderful folks from the @MSAtlantic Society, a cause that is dear to me, having seen the impact of #MultipleSclerosis on relatives and friends. For anyone seeking support with #MS, #MSNavigators is a great support resource: https://t.co/ESp5lBFtal… https://t.co/pTsQTfapz8"

Zoe Bowman, 43, from Crystal Palace, was diagnosed with primary progressive form of MS in 2017. She said the new drug gives her a 'glimmer of hope for the future'Zoe Bowman, 43, from Crystal Palace, was diagnosed with primary progressive form of MS in 2017. She said the new drug gives her a 'glimmer of hope for the future'

Health watchdog approves first ever treatment for progressive form of MS in massive U-turn | Daily Mail Online

Multiple Sclerosis (MS) patients have welcomed an NHS decision to fund a “landmark” drug which can delay the need for a wheelchair by seven years.Multiple Sclerosis (MS) patients have welcomed an NHS decision to fund a “landmark” drug which can delay the need for a wheelchair by seven years.

Hope for multiple sclerosis sufferers after green light for drug which can delay wheelchair use by seven years